About Myovant Sciences
We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
|
|
51-200 employees
View all Myovant Sciences employees
|
|
Biotechnology
|
|
2000 Sierra Point Parkway, 9th Floor, Brisbane, CA 94005, US
|
|
2016
|
Myovant Sciences Alternatives
Frequently Asked Questions about Myovant Sciences
Naama Bar is the CEO of Myovant Sciences. To contact Naama Bar email at [email protected].
The decision makers in Myovant Sciences are Andrew Zoltan, Andy R, Griffin Barbula, etc. Click to Find Myovant Sciences decision makers emails.
Myovant Sciences Staff Directory
Search Myovant Sciences Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
